• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可控制的氧化型低密度脂蛋白细胞摄取抑制:纳米两亲聚合物的结构-功能关系。

Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.

机构信息

Department of Biomedical Engineering, Rutgers University, Piscataway, NJ 08854, USA.

出版信息

Acta Biomater. 2010 Aug;6(8):3081-91. doi: 10.1016/j.actbio.2010.02.019. Epub 2010 Feb 17.

DOI:10.1016/j.actbio.2010.02.019
PMID:20170758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2882988/
Abstract

A family of anionic nanoscale polymers based on amphiphilic macromolecules (AMs) was developed for controlled inhibition of highly oxidized low-density lipoprotein (hoxLDL) uptake by inflammatory macrophage cells, a process that triggers the escalation of a chronic arterial disease called atherosclerosis. The basic AM structure is composed of a hydrophobic portion formed from a mucic acid sugar backbone modified at the four hydroxyls with lauroyl groups conjugated to hydrophilic poly(ethylene glycol) (PEG). The AM structure-activity relationships were probed by synthesizing AMs with six key variables: length of the PEG chain, carboxylic acid location, type of anionic charge, number of anionic charges, rotational motion of the anionic group, and PEG architecture. All AM structures were confirmed by nuclear magnetic resonance spectroscopy and their ability to inhibit hoxLDL uptake in THP-1 human macrophage cells was compared in the absence and presence of serum. We report that AMs with one, rotationally restricted carboxylic acid within the hydrophobic portion of the polymer was sufficient to yield the most effective AM for inhibiting hoxLDL internalization by THP-1 human macrophage cells under serum-containing conditions. Further, increasing the number of charges and altering the PEG architecture in an effort to increase serum stabilization did not significantly impair the ability of AMs to inhibit hoxLDL internalization, suggesting that selected modifications to the AMs could potentially promote multifunctional characteristics of these nanoscale macromolecules.

摘要

基于两亲性大分子 (AM) 的阴离子纳米级聚合物家族被开发出来,用于控制炎症巨噬细胞对高度氧化的低密度脂蛋白 (hoxLDL) 的摄取,这一过程引发了一种称为动脉粥样硬化的慢性动脉疾病的恶化。基本的 AM 结构由疏水部分组成,疏水部分由粘酸糖主链构成,四个羟基用连接到亲水聚乙二醇 (PEG) 的月桂酰基修饰。通过合成具有六个关键变量的 AM 来探究 AM 的结构-活性关系:PEG 链的长度、羧酸的位置、阴离子电荷的类型、阴离子电荷的数量、阴离子基团的旋转运动和 PEG 结构。所有 AM 结构均通过核磁共振波谱法确认,并在无血清和有血清的情况下比较它们抑制 THP-1 人巨噬细胞摄取 hoxLDL 的能力。我们报告说,聚合物疏水部分中带有一个旋转受限的羧酸的 AM 足以产生最有效的 AM,可在含血清条件下抑制 THP-1 人巨噬细胞摄取 hoxLDL。此外,增加电荷数量并改变 PEG 结构以努力增加血清稳定性并没有显著削弱 AM 抑制 hoxLDL 内化的能力,这表明对 AM 的某些修饰可能会潜在地促进这些纳米级大分子的多功能特性。

相似文献

1
Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.可控制的氧化型低密度脂蛋白细胞摄取抑制:纳米两亲聚合物的结构-功能关系。
Acta Biomater. 2010 Aug;6(8):3081-91. doi: 10.1016/j.actbio.2010.02.019. Epub 2010 Feb 17.
2
Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture.纳米级两亲性大分子作为脂蛋白抑制剂:电荷与结构的作用
Int J Nanomedicine. 2007;2(4):697-705.
3
Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL.纳米级阴离子大分子可抑制细胞对不同氧化程度的低密度脂蛋白的摄取。
Biomacromolecules. 2006 Feb;7(2):597-603. doi: 10.1021/bm0506905.
4
Impact of hydrophobic chain composition on amphiphilic macromolecule antiatherogenic bioactivity.疏水链组成对两亲性大分子抗动脉粥样硬化生物活性的影响。
Biomacromolecules. 2014 Sep 8;15(9):3328-37. doi: 10.1021/bm500809f. Epub 2014 Aug 6.
5
Nanoscale amphiphilic macromolecules with variable lipophilicity and stereochemistry modulate inhibition of oxidized low-density lipoprotein uptake.具有可变疏水性和立体化学的纳米级两亲性大分子调节氧化型低密度脂蛋白摄取的抑制作用。
Biomacromolecules. 2013 Aug 12;14(8):2463-9. doi: 10.1021/bm400537w. Epub 2013 Jul 8.
6
Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages.工程化聚合物纳米颗粒用于受体靶向阻断巨噬细胞中氧化低密度脂蛋白的摄取及动脉粥样硬化的发生。
Biomacromolecules. 2006 Jun;7(6):1796-805. doi: 10.1021/bm0600872.
7
Coarse grained molecular dynamics of engineered macromolecules for the inhibition of oxidized low-density lipoprotein uptake by macrophage scavenger receptors.工程化大分子的粗粒分子动力学研究用于抑制巨噬细胞清道夫受体摄取氧化型低密度脂蛋白。
Biomacromolecules. 2013 Aug 12;14(8):2499-509. doi: 10.1021/bm301764x. Epub 2013 Jul 3.
8
Micellar and structural stability of nanoscale amphiphilic polymers: Implications for anti-atherosclerotic bioactivity.纳米级两亲聚合物的胶束与结构稳定性:对抗动脉粥样硬化生物活性的影响。
Biomaterials. 2016 Apr;84:230-240. doi: 10.1016/j.biomaterials.2015.12.028. Epub 2016 Jan 6.
9
In silico design of anti-atherogenic biomaterials.抗动脉粥样硬化生物材料的计算机辅助设计。
Biomaterials. 2013 Oct;34(32):7950-9. doi: 10.1016/j.biomaterials.2013.07.011. Epub 2013 Jul 25.
10
Efficient intracellular siRNA delivery by ethyleneimine-modified amphiphilic macromolecules.通过乙撑亚胺修饰的两亲性大分子实现高效的细胞内 siRNA 传递。
Macromol Biosci. 2011 Sep 9;11(9):1192-200. doi: 10.1002/mabi.201100064. Epub 2011 Jul 26.

引用本文的文献

1
PCSK9 gene Polymorphism and Assessment of Cardiovascular Risk and Prognosis in Patients With Hyperlipidemia: A Retrospective Cohort Study.PCSK9基因多态性与高脂血症患者心血管风险及预后评估:一项回顾性队列研究
J Clin Hypertens (Greenwich). 2025 Aug;27(8):e70120. doi: 10.1111/jch.70120.
2
Reduced Uptake of Oxidized Low-Density Lipoprotein by Macrophages Using Multiple Aptamer Combinations.使用多种适体组合降低巨噬细胞对氧化型低密度脂蛋白的摄取
ACS Appl Bio Mater. 2025 Jan 20;8(1):457-474. doi: 10.1021/acsabm.4c01432. Epub 2025 Jan 6.
3
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer's pathology.

本文引用的文献

1
Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A.纳米脂质阻滞剂与人类巨噬细胞清道夫受体A致动脉粥样化结构域的构效关系
Biomacromolecules. 2009 Jun 8;10(6):1381-91. doi: 10.1021/bm8014522.
2
Comparison of PEG chain length and density on amphiphilic macromolecular nanocarriers: self-assembled and unimolecular micelles.两亲性大分子纳米载体上聚乙二醇链长度和密度的比较:自组装和单分子胶束
Acta Biomater. 2009 Mar;5(3):883-92. doi: 10.1016/j.actbio.2008.10.019. Epub 2008 Nov 8.
3
Amphiphilic block copolymers enhance cellular uptake and nuclear entry of polyplex-delivered DNA.
用于针对小胶质细胞和抑制阿尔茨海默病病理学中神经炎症的纳米技术。
Transl Neurodegener. 2024 Jan 4;13(1):2. doi: 10.1186/s40035-023-00393-7.
4
CD36-Binding Amphiphilic Nanoparticles for Attenuation of Alpha Synuclein-Induced Microglial Activation.用于减轻α-突触核蛋白诱导的小胶质细胞活化的CD36结合两亲性纳米颗粒
Adv Nanobiomed Res. 2022 Jun;2(6). doi: 10.1002/anbr.202100120. Epub 2022 Mar 22.
5
The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy.脂蛋白在动脉粥样硬化中的功能作用:诊断与靶向治疗的新方向
Aging Dis. 2022 Apr 1;13(2):491-520. doi: 10.14336/AD.2021.0929. eCollection 2022 Apr.
6
Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential.低密度脂蛋白纳米药物:靶向机制、生物学和治疗诊断潜力。
Drug Deliv. 2021 Dec;28(1):408-421. doi: 10.1080/10717544.2021.1886199.
7
Nanotherapeutics Containing Lithocholic Acid-Based Amphiphilic Scorpion-Like Macromolecules Reduce In Vitro Inflammation in Macrophages: Implications for Atherosclerosis.含有基于石胆酸的两亲性蝎形大分子的纳米治疗剂可减轻巨噬细胞的体外炎症:对动脉粥样硬化的影响。
Nanomaterials (Basel). 2018 Feb 2;8(2):84. doi: 10.3390/nano8020084.
8
Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation.动脉粥样硬化炎症纳米疗法:基于阿魏酸的聚(酸酐-酯)纳米颗粒通过调节巨噬细胞脂肪生成和活性氧生成来减轻泡沫细胞形成。
Acta Biomater. 2017 Jul 15;57:85-94. doi: 10.1016/j.actbio.2017.05.029. Epub 2017 May 15.
9
Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.用于多靶点抑制小胶质细胞α-突触核蛋白聚集、激活和神经毒性的聚合物脑纳米疗法。
Biomaterials. 2016 Dec;111:179-189. doi: 10.1016/j.biomaterials.2016.10.001. Epub 2016 Oct 4.
10
Micellar and structural stability of nanoscale amphiphilic polymers: Implications for anti-atherosclerotic bioactivity.纳米级两亲聚合物的胶束与结构稳定性:对抗动脉粥样硬化生物活性的影响。
Biomaterials. 2016 Apr;84:230-240. doi: 10.1016/j.biomaterials.2015.12.028. Epub 2016 Jan 6.
两亲性嵌段共聚物可增强多聚体递送的DNA的细胞摄取和核内进入。
Bioconjug Chem. 2008 Oct;19(10):1987-94. doi: 10.1021/bc800144a. Epub 2008 Aug 27.
4
Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture.纳米级两亲性大分子作为脂蛋白抑制剂:电荷与结构的作用
Int J Nanomedicine. 2007;2(4):697-705.
5
Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.在缺乏肝X受体α(LXRα)和载脂蛋白E(apoE)的小鼠中,LXRβ的配体激活可逆转动脉粥样硬化和细胞胆固醇过载。
J Clin Invest. 2007 Aug;117(8):2337-46. doi: 10.1172/JCI31909.
6
Complexation and release of doxorubicin from its complexes with pluronic P85-b-poly(acrylic acid) block copolymers.阿霉素与其与普朗尼克P85-b-聚(丙烯酸)嵌段共聚物形成的复合物的络合及释放
J Control Release. 2007 Aug 28;121(3):137-45. doi: 10.1016/j.jconrel.2007.05.010. Epub 2007 May 17.
7
Size comparison between proteins PEGylated with branched and linear poly(ethylene glycol) molecules.用支链和线性聚乙二醇分子聚乙二醇化的蛋白质之间的大小比较。
Biotechnol Bioeng. 2007 Nov 1;98(4):725-31. doi: 10.1002/bit.21482.
8
Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol).巨噬细胞对用聚乙二醇表面修饰的核壳纳米颗粒的摄取。
Langmuir. 2006 Sep 12;22(19):8178-85. doi: 10.1021/la060951b.
9
Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages.工程化聚合物纳米颗粒用于受体靶向阻断巨噬细胞中氧化低密度脂蛋白的摄取及动脉粥样硬化的发生。
Biomacromolecules. 2006 Jun;7(6):1796-805. doi: 10.1021/bm0600872.
10
Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL.纳米级阴离子大分子可抑制细胞对不同氧化程度的低密度脂蛋白的摄取。
Biomacromolecules. 2006 Feb;7(2):597-603. doi: 10.1021/bm0506905.